Status
Conditions
About
Patients with treatment-naive obstructive sleep apnea (OSA) who need continuous positive airway pressure (CPAP) therapy on clinical basis are included as well as healthy controls without OSA. 15 cc peripheral venous blood is drawn on the date of diagnosis of OSA and 3-6 months after CPAP therapy. Granulocytes are harvested and tested for its function, such as phagocytosis, reactive oxygen species (ROS) production and bacteria-killing ability.
Full description
Patients with treatment-naive obstructive sleep apnea (OSA) who need continuous positive airway pressure (CPAP) therapy on clinical basis are included. Healthy controls without OSA are enrolled, too. 15 cc peripheral venous blood is drawn on the date of diagnosis of OSA and 3-6 months after CPAP therapy (not given to controls). Granulocytes are harvested and tested for its function, such as phagocytosis, reactive oxygen species (ROS) production and bacteria-killing ability.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
<OSA group> 1. Patients with treatment-naive obstructive sleep apnea (OSA) who need continuous positive airway pressure (CPAP) therapy on clinical basis 2. aged 20 years or older 3. Apnea-hypopnea index (AHI) at least 15/hour 4. Willing to participate this study <Control group>
Exclusion criteria
<OSA group>
OSA patients who do not need continuous positive airway pressure (CPAP) therapy
OSA Patients have ever received CPAP or other treatment
aged less than 20 years
AHI at least 15/hour
Not willing to participate this study <Control group>
Apnea-hypopnea index (AHI) equals to or more than 5/hour 2. aged less than 20 years 3. Not willing to participate this study
40 participants in 2 patient groups
Loading...
Central trial contact
Kun-Ta Chou, M.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal